UK schizophrenia drug market is projected to grow at a significant CAGR of around 2.7% during the forecast period. UK has a well-developed healthcare infrastructure with an established mental health facility. National Health Services (NHS) England spends $7.2 million per year on mental health services for ex-service personnel, in addition to the $12.7 billion spending […]
